These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6781157)

  • 1. [Average time prognosis of hypertension in qualitatively different treatment protocols].
    Knappe J; Dück KD; Strube G; Holtz H; Heinrich J
    Z Gesamte Inn Med; 1980 Nov; 35(21):suppl 136-8. PubMed ID: 6781157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term treatment of arterial hypertension with propranolol. Combination with diuretics and dihydrazinophthalazine].
    Pessina AC; Corgnati A; Palatini P; Ambrosio G; Dal Palù C
    Minerva Med; 1978 Feb; 69(7):437-43. PubMed ID: 634495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of long-term therapy in hypertension].
    Herrmann RM; Kiesewetter R; Kuhn J
    Z Gesamte Inn Med; 1980 Nov; 35(21):suppl 134-6. PubMed ID: 6781156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penbutolol and arterial hypertension].
    Torriani A; Bravi M; Broglia M; Giuffrè G; Carisdeo V
    Minerva Med; 1987 Sep; 78(18):1375-80. PubMed ID: 3658210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2003 Mar; 128(11):541-4. PubMed ID: 12635025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of propranolol in essential hypertension--results of a 10-year therapeutic course study].
    Dück KD; Knappe J
    Z Gesamte Inn Med; 1983 Dec; 38(23):640-4. PubMed ID: 6670340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)].
    Ebel H; Lübke H; Klaus D; Zehner J; Witzgall H
    Dtsch Med Wochenschr; 1978 Oct; 103(42):1650-5. PubMed ID: 699788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on combination treatment of chronic hypertension].
    Schröder HE; Thiele P
    Z Arztl Fortbild (Jena); 1981 Apr; 75(8):356-61. PubMed ID: 7281778
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].
    Förster A; Smolka W; Jung C; Bestehorn K
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():111-8. PubMed ID: 17955788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.